What causes bypass graft failure

Overview

Coronary artery bypass grafting (CABG) is a life-saving surgical procedure designed to restore adequate blood flow to the heart muscle when coronary arteries become severely narrowed or blocked by atherosclerotic plaque. This condition, often referred to as coronary artery disease (CAD), can lead to angina (chest pain), shortness of breath, and ultimately, myocardial infarction (heart attack). CABG involves harvesting a healthy blood vessel (a graft) from another part of the body, such as the leg (saphenous vein), chest (internal mammary artery), or arm (radial artery), or using a synthetic tube. This graft is then attached to the aorta (the main artery carrying blood from the heart) and to the coronary artery beyond the blockage, creating a new pathway for blood to flow to the heart muscle.

Despite the success of CABG in relieving symptoms and improving survival rates, bypass grafts are not immune to failure. Graft failure refers to the loss of patency, meaning the graft becomes narrowed or completely blocked, rendering it ineffective. This failure can occur at various times after surgery, from immediately post-operatively to many years later, and is a significant concern for patients and clinicians as it can lead to a recurrence of symptoms, further cardiac events, and the need for additional interventions.

Details on Causes of Bypass Graft Failure

1. Atherosclerosis Progression

The most prevalent cause of bypass graft failure is the progression of the underlying atherosclerotic disease. While the bypass reroutes blood around blockages in the native coronary arteries, the disease process itself can affect the graft vessels and the remaining native arteries. Atherosclerosis is a chronic inflammatory condition characterized by the buildup of fatty deposits, cholesterol, calcium, and other substances within the artery walls, forming plaques. These plaques can:

• Affect the Native Coronary Arteries: The disease process that caused the initial blockages can continue to affect the coronary arteries downstream from the anastomosis (the surgical connection point of the graft). New blockages can form, or existing ones can worsen, compromising blood flow.
• Affect the Graft Itself: Vein grafts, in particular, are susceptible to developing atherosclerotic changes over time. The different hemodynamic (blood flow) and cellular environment in a vein graft compared to an artery can promote the development of atherosclerosis within the graft wall. This can lead to narrowing and eventual occlusion. Studies have shown that a significant percentage of vein grafts develop atherosclerotic lesions within years of surgery.
• Affect the Anastomoses: Both the proximal anastomosis (where the graft connects to the aorta) and the distal anastomosis (where it connects to the coronary artery) can become sites for plaque buildup, contributing to graft failure.

2. Graft Thrombosis

Graft thrombosis refers to the formation of a blood clot within the graft, leading to sudden and complete occlusion. This is the most common cause of early graft failure, often occurring within the first few days to weeks after surgery. Several factors can predispose a graft to thrombosis:

• Technical Errors During Surgery: Poor surgical technique, such as inadequate blood flow velocity within the graft, "kinking" of the graft, or incomplete removal of intimal lining from the vein graft, can create conditions favorable for clot formation.
• Hypercoagulability: Certain medical conditions or medications can make the blood more prone to clotting.
• Graft Injury: Damage to the graft during harvesting or implantation can trigger the clotting cascade.
• Early Atherosclerotic Changes: Even in the early stages, damage to the graft endothelium (inner lining) can initiate thrombus formation.

The sudden blockage of a graft by a thrombus is a critical event, as it can lead to acute myocardial infarction if the graft was crucial for supplying blood to a significant area of the heart muscle.

3. Intimal Hyperplasia

Intimal hyperplasia is a key pathological process responsible for late graft failure, typically occurring between 1 and 5 years after surgery, although it can manifest earlier or later. It is characterized by the excessive proliferation and migration of smooth muscle cells from the media (middle layer) of the vessel wall into the intima (inner layer). This thickening of the intima narrows the lumen of the graft, impeding blood flow.

• Mechanism: Intimal hyperplasia is thought to be a response to injury or abnormal hemodynamic forces within the graft. In vein grafts, the altered pressure and shear stress, along with inflammatory mediators released from endothelial cells, stimulate smooth muscle cells to proliferate.
• Vein Grafts vs. Arterial Grafts: Vein grafts are significantly more prone to intimal hyperplasia than arterial grafts. Arterial grafts, such as the internal mammary artery (IMA) and radial artery, have a different cellular structure and are better adapted to arterial pressure and flow, making them more resistant to this process.

The gradual narrowing caused by intimal hyperplasia can lead to the return of angina symptoms and may eventually progress to complete occlusion.

4. Graft Material Choice and Longevity

The type of graft material used plays a crucial role in the long-term patency rates of bypass grafts:

• Saphenous Vein Grafts (SVGs): These are the most commonly used grafts but have a higher failure rate over time compared to arterial grafts. Their patency rates typically range from 80-90% at 1 year, decreasing to around 50-70% at 5 years and further declining thereafter.
• Internal Mammary Artery (IMA) Grafts: Particularly the left IMA, these grafts demonstrate superior long-term patency rates, often exceeding 90% patency at 10 years and beyond. This is attributed to their inherent resistance to atherosclerosis and intimal hyperplasia.
• Radial Artery Grafts: These arterial grafts also offer good long-term patency, generally better than vein grafts, but may be more susceptible to vasospasm.
• Synthetic Grafts: While used in some situations (e.g., peripheral bypass), synthetic grafts are generally not preferred for coronary bypass due to a higher risk of thrombosis and infection.

5. Patient-Specific Risk Factors

Several patient characteristics and comorbidities significantly influence the likelihood of bypass graft failure:

• Diabetes Mellitus: Diabetic patients have a higher risk of accelerated atherosclerosis and intimal hyperplasia in their grafts, leading to poorer long-term outcomes.
• Hypertension (High Blood Pressure): Uncontrolled hypertension can accelerate graft disease and increase the mechanical stress on the grafts.
• Hyperlipidemia (High Cholesterol): Elevated cholesterol levels contribute directly to the development and progression of atherosclerosis in both native vessels and grafts.
• Smoking: Current smokers have a significantly higher risk of graft failure compared to non-smokers. Smoking promotes endothelial dysfunction and accelerates atherosclerotic processes.
• Obesity: While not a direct cause, obesity is often associated with other risk factors like diabetes, hypertension, and hyperlipidemia.
• Kidney Disease: Impaired kidney function is associated with increased cardiovascular risk and can negatively impact graft longevity.

6. Inflammation and Endothelial Dysfunction

Chronic inflammation and dysfunction of the endothelial cells lining the blood vessels (including the grafts) play a critical role in the development of atherosclerosis and intimal hyperplasia. Factors like diabetes, hypertension, and hyperlipidemia contribute to endothelial dysfunction, making the vessel wall more prone to plaque formation and abnormal cellular responses.

Conclusion

Bypass graft failure is a multifactorial process resulting from the interplay of the underlying disease, the characteristics of the graft material, surgical technique, and patient-specific risk factors. While significant advancements have been made in surgical techniques and graft management, ongoing medical management and lifestyle modifications remain crucial for maximizing the longevity of bypass grafts and ensuring the long-term success of CABG surgery. Patients experiencing recurrent symptoms after CABG should consult their cardiologist to evaluate graft function and discuss potential treatment options.